Biotinidase deficiency is an inherited disease in which the human body cannot process biotin (vitamin B7), due to deficiency in an enzyme called biotinidase. Deficiency of biotinidase is due to mutations in the BTD gene. Other factors causing biotin deficiency are prolonged treatment with anticonvulsants, ingestion of high doses of lipoic acid, long-term use of antibiotics, and excessive alcohol consumption.
MARKET DYNAMICS
The biotinidase deficiency market is driving due to the growing strict long-term dieting, increasing awareness of the people towards aesthetic treatment and increasing prevalence of genetic disorders. Furthermore, growing demand for nutritional supplements from emerging markets will create lucrative opportunities in the market.
MARKET SCOPE
The "Biotinidase Deficiency Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biotinidase deficiency market with detailed market segmentation by category, consumer type, application, dosage form, age group, and end user. The biotinidase deficiency market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biotinidase deficiency market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biotinidase deficiency market is segmented on the basis of category, consumer type, application, dosage form, age group, and end user. Based on category, the market is segmented as profound biotinidase deficiency, and partial biotinidase deficiency. On the basis of consumer type, the market is categorized as men, women, and kids. Based on application, the market is segmented into skincare, hair care, nails care, and other. The dosage form segment is segmented into capsules, tablets, soft gels, liquid, powder, and other. On the basis of age group the market is segmented into 0 -16 years, 17 - 35 years, 30 - 60 years, and 60+ years. The end user market is segmented into hospitals, speciality clinics, drug stores, retail pharmacy, and online pharmacy.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biotinidase deficiency market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biotinidase deficiency market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biotinidase deficiency market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biotinidase deficiency market in these regions.
MARKET PLAYERS
The report covers key developments in the biotinidase deficiency market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biotinidase deficiency market are anticipated to have lucrative growth opportunities in the future with the rising demand for biotinidase deficiency in the global market. Below mentioned is the list of few companies engaged in the biotinidase deficiency market.
The report also includes the profiles of key players in biotinidase deficiency market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- LIFE GARDEN NATURALS
- ZHOU NUTRITION LLC
- PURE RESEARCH PRODUCTS LLC
- SBR NUTRITION
- NATROL LLC
- CHURCH AND DWIGHT CO. INC
- ZENWISE HEALTH LLC
- MERICON INDUSTRIES, INC
- SOLACE NUTRITION
- HOLLAND AND BARRETT
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.